Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Irvin Hudson, M.D.

Co-Author

This page shows the publications co-authored by James Hudson and Harrison Pope.
Connection Strength

15.079
  1. Hudson JI, Pope HG. Evolving Perspectives on the Public Health Burden of Eating Disorders. Biol Psychiatry. 2018 09 01; 84(5):318-319.
    View in: PubMed
    Score: 0.857
  2. Pope HG, Kanayama G, Hudson JI. Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biol Psychiatry. 2012 Feb 01; 71(3):254-61.
    View in: PubMed
    Score: 0.525
  3. Hudson JI, Coit CE, Lalonde JK, Pope HG. By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder? Int J Eat Disord. 2012 Jan; 45(1):139-41.
    View in: PubMed
    Score: 0.502
  4. Hudson JI, Lalonde JK, Coit CE, Tsuang MT, McElroy SL, Crow SJ, Bulik CM, Hudson MS, Yanovski JA, Rosenthal NR, Pope HG. Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder. Am J Clin Nutr. 2010 Jun; 91(6):1568-73.
    View in: PubMed
    Score: 0.481
  5. Pope HG, Poliakoff MB, Parker MP, Boynes M, Hudson JI. Ignoring Nina: Avoidance and denial in Pope, Poliakoff, Parker, Boynes, and Hudson. J Trauma Dissociation. 2010; 11(1):19-20; author reply 21.
    View in: PubMed
    Score: 0.470
  6. Hudson JI, Pope HG. Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypes. Int J Eat Disord. 2007 Nov; 40 Suppl:S76-8.
    View in: PubMed
    Score: 0.404
  7. Pope HG, Poliakoff MB, Parker MP, Boynes M, Hudson JI. Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literature. Psychol Med. 2007 Feb; 37(2):225-33.
    View in: PubMed
    Score: 0.380
  8. Pope HG, Lalonde JK, Pindyck LJ, Walsh T, Bulik CM, Crow SJ, McElroy SL, Rosenthal N, Hudson JI. Binge eating disorder: a stable syndrome. Am J Psychiatry. 2006 Dec; 163(12):2181-3.
    View in: PubMed
    Score: 0.379
  9. Hudson JI, Lalonde JK, Berry JM, Pindyck LJ, Bulik CM, Crow SJ, McElroy SL, Laird NM, Tsuang MT, Walsh BT, Rosenthal NR, Pope HG. Binge-eating disorder as a distinct familial phenotype in obese individuals. Arch Gen Psychiatry. 2006 Mar; 63(3):313-9.
    View in: PubMed
    Score: 0.360
  10. Pope HG, Barry S, Bodkin A, Hudson JI. Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003. Psychother Psychosom. 2006; 75(1):19-24.
    View in: PubMed
    Score: 0.356
  11. Hudson JI, Arnold LM, Keck PE, Auchenbach MB, Pope HG. Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry. 2004 Dec 01; 56(11):884-91.
    View in: PubMed
    Score: 0.330
  12. Pope HG, Kanayama G, Ionescu-Pioggia M, Hudson JI. Anabolic steroid users' attitudes towards physicians. Addiction. 2004 Sep; 99(9):1189-94.
    View in: PubMed
    Score: 0.325
  13. Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Jan; 160(1):105-11.
    View in: PubMed
    Score: 0.289
  14. Hudson JI, Laird NM, Betensky RA, Keck PE, Pope HG. Multivariate logistic regression for familial aggregation of two disorders. II. Analysis of studies of eating and mood disorders. Am J Epidemiol. 2001 Mar 01; 153(5):506-14.
    View in: PubMed
    Score: 0.255
  15. Pope HG, Gruber AJ, Mangweth B, Bureau B, deCol C, Jouvent R, Hudson JI. Body image perception among men in three countries. Am J Psychiatry. 2000 Aug; 157(8):1297-301.
    View in: PubMed
    Score: 0.245
  16. Hudson JI, Kanayama G, Pope HG, Muse S, Kaufman MJ, Baggish A, Waikar SS. Glomerular Filtration Rate and Supraphysiologic-Dose Anabolic-Androgenic Steroid Use: A Cross-sectional Cohort Study. Am J Kidney Dis. 2020 07; 76(1):152-155.
    View in: PubMed
    Score: 0.240
  17. Kanayama G, Hudson JI, Pope HG. Anabolic-Androgenic Steroid Use and Body Image in Men: A Growing Concern for Clinicians. Psychother Psychosom. 2020; 89(2):65-73.
    View in: PubMed
    Score: 0.237
  18. Pope HG, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry. 2000 Feb; 57(2):133-40; discussion 155-6.
    View in: PubMed
    Score: 0.236
  19. Kaufman MJ, Kanayama G, Hudson JI, Pope HG. Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Neurosci Biobehav Rev. 2019 05; 100:180-207.
    View in: PubMed
    Score: 0.222
  20. Hudson JI, Chase EA, Pope HG. Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. Int J Eat Disord. 1998 Jan; 23(1):1-5.
    View in: PubMed
    Score: 0.205
  21. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23; 135(21):1991-2002.
    View in: PubMed
    Score: 0.196
  22. Hudson JI, Pope HG. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am. 1996 May; 22(2):285-303.
    View in: PubMed
    Score: 0.182
  23. Pope HG, Hudson JI. "Recovered memory" therapy for eating disorders: implications of the Ramona verdict. Int J Eat Disord. 1996 Mar; 19(2):139-45.
    View in: PubMed
    Score: 0.180
  24. Hudson JI, Carter WP, Pope HG. Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. J Clin Psychiatry. 1996; 57 Suppl 8:73-9.
    View in: PubMed
    Score: 0.178
  25. Kanayama G, DeLuca J, Meehan WP, Hudson JI, Isaacs S, Baggish A, Weiner R, Micheli L, Pope HG. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study. Am J Sports Med. 2015 Nov; 43(11):2638-44.
    View in: PubMed
    Score: 0.174
  26. Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2015 Jul 01; 152:47-56.
    View in: PubMed
    Score: 0.170
  27. Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015 May; 110(5):823-31.
    View in: PubMed
    Score: 0.168
  28. Pope HG, Hudson JI. Can memories of childhood sexual abuse be repressed? Psychol Med. 1995 Jan; 25(1):121-6.
    View in: PubMed
    Score: 0.166
  29. Hudson JI, Pope HG. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol. 1994 Nov; 8(4):839-56.
    View in: PubMed
    Score: 0.164
  30. Brennan BP, Lee C, Elias JA, Crosby JM, Mathes BM, Andre MC, Gironda CM, Pope HG, Jenike MA, Fitzmaurice GM, Hudson JI. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response. J Psychiatr Res. 2014 Sep; 56:98-105.
    View in: PubMed
    Score: 0.159
  31. Pope HG, Katz DL, Hudson JI. Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. Compr Psychiatry. 1993 Nov-Dec; 34(6):406-9.
    View in: PubMed
    Score: 0.153
  32. Pope HG, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict. 2014 Jul-Aug; 23(4):371-7.
    View in: PubMed
    Score: 0.152
  33. Hudson JI, Lipinski JF, Keck PE, Aizley HG, Vuckovic A, Zierk KC, Pope HG. Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry. 1993 Aug 01; 34(3):191-3.
    View in: PubMed
    Score: 0.151
  34. Kanayama G, Kean J, Hudson JI, Pope HG. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013 Jun 01; 130(1-3):208-14.
    View in: PubMed
    Score: 0.144
  35. Pope HG, Hudson JI. Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry. 1992 Apr; 149(4):455-63.
    View in: PubMed
    Score: 0.137
  36. Kanayama G, Hudson JI, Pope HG. Culture, psychosomatics and substance abuse: the example of body image drugs. Psychother Psychosom. 2012; 81(2):73-8.
    View in: PubMed
    Score: 0.135
  37. Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction. 2011 Apr; 106(4):777-86.
    View in: PubMed
    Score: 0.127
  38. Pope HG, Hudson JI. A supplemental interview for forms of "affective spectrum disorder". Int J Psychiatry Med. 1991; 21(3):205-32.
    View in: PubMed
    Score: 0.126
  39. Pope HG, McElroy SL, Keck PE, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry. 1991 Jan; 48(1):62-8.
    View in: PubMed
    Score: 0.126
  40. Brennan BP, Kanayama G, Hudson JI, Pope HG. Human growth hormone abuse in male weightlifters. Am J Addict. 2011 Jan-Feb; 20(1):9-13.
    View in: PubMed
    Score: 0.125
  41. Hudson JI, Pope HG. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry. 1990 May; 147(5):552-64.
    View in: PubMed
    Score: 0.120
  42. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Pope HG. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010 Jul; 3(4):472-6.
    View in: PubMed
    Score: 0.120
  43. Pope HG, Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010 Apr; 30(2):126-34.
    View in: PubMed
    Score: 0.120
  44. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):6-13.
    View in: PubMed
    Score: 0.119
  45. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009 Dec; 104(12):1966-78.
    View in: PubMed
    Score: 0.117
  46. Hudson JI, Pope HG. Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol Suppl. 1989 Nov; 19:15-22.
    View in: PubMed
    Score: 0.116
  47. Kanayama G, Hudson JI, Pope HG. Illicit anabolic-androgenic steroid use. Horm Behav. 2010 Jun; 58(1):111-21.
    View in: PubMed
    Score: 0.115
  48. Pope HG, Keck PE, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol. 1989 Aug; 9(4):254-9.
    View in: PubMed
    Score: 0.114
  49. Brennan BP, Fogarty KV, Roberts JL, Reynolds KA, Pope HG, Hudson JI. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Hum Psychopharmacol. 2009 Jul; 24(5):423-8.
    View in: PubMed
    Score: 0.113
  50. Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG. Issues for DSM-V: clarifying the diagnostic criteria for anabolic-androgenic steroid dependence. Am J Psychiatry. 2009 Jun; 166(6):642-5.
    View in: PubMed
    Score: 0.113
  51. Kanayama G, Hudson JI, Pope HG. Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):130-7.
    View in: PubMed
    Score: 0.112
  52. McElroy SL, Guerdjikova AI, Martens B, Keck PE, Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs. 2009; 23(2):139-56.
    View in: PubMed
    Score: 0.110
  53. Kanayama G, Hudson JI, Pope HG. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 01; 98(1-2):1-12.
    View in: PubMed
    Score: 0.106
  54. Hudson JI, Javaras KN, Laird NM, VanderWeele TJ, Pope HG, Hernán MA. A structural approach to the familial coaggregation of disorders. Epidemiology. 2008 May; 19(3):431-9.
    View in: PubMed
    Score: 0.105
  55. Javaras KN, Laird NM, Reichborn-Kjennerud T, Bulik CM, Pope HG, Hudson JI. Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study. Int J Eat Disord. 2008 Mar; 41(2):174-9.
    View in: PubMed
    Score: 0.103
  56. Javaras KN, Pope HG, Lalonde JK, Roberts JL, Nillni YI, Laird NM, Bulik CM, Crow SJ, McElroy SL, Walsh BT, Tsuang MT, Rosenthal NR, Hudson JI. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry. 2008 Feb; 69(2):266-73.
    View in: PubMed
    Score: 0.103
  57. Pope HG, Champoux RF, Hudson JI. Eating disorder and socioeconomic class. Anorexia nervosa and bulimia in nine communities. J Nerv Ment Dis. 1987 Oct; 175(10):620-3.
    View in: PubMed
    Score: 0.101
  58. Pope HG, Hudson JI. Antidepressant medication in the treatment of bulimia nervosa. Psychopathology. 1987; 20 Suppl 1:123-9.
    View in: PubMed
    Score: 0.095
  59. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007 May 11; 88(2-3):156-62.
    View in: PubMed
    Score: 0.095
  60. Bodkin JA, Pope HG, Detke MJ, Hudson JI. Is PTSD caused by traumatic stress? J Anxiety Disord. 2007; 21(2):176-82.
    View in: PubMed
    Score: 0.094
  61. Hudson JI, Hiripi E, Pope HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 01; 61(3):348-58.
    View in: PubMed
    Score: 0.092
  62. Kanayama G, Barry S, Hudson JI, Pope HG. Body image and attitudes toward male roles in anabolic-androgenic steroid users. Am J Psychiatry. 2006 Apr; 163(4):697-703.
    View in: PubMed
    Score: 0.091
  63. Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005 Oct 15; 58(8):624-31.
    View in: PubMed
    Score: 0.088
  64. Hudson JI, Pope HG, Glynn RJ. The cross-sectional cohort study: an underutilized design. Epidemiology. 2005 May; 16(3):355-9.
    View in: PubMed
    Score: 0.085
  65. Mangweth B, Hausmann A, Danzl C, Walch T, Rupp CI, Biebl W, Hudson JI, Pope HG. Childhood body-focused behaviors and social behaviors as risk factors of eating disorders. Psychother Psychosom. 2005; 74(4):247-53.
    View in: PubMed
    Score: 0.083
  66. Mangweth B, Hausmann A, Walch T, Hotter A, Rupp CI, Biebl W, Hudson JI, Pope HG. Body fat perception in eating-disordered men. Int J Eat Disord. 2004 Jan; 35(1):102-8.
    View in: PubMed
    Score: 0.078
  67. Kanayama G, Pope HG, Cohane G, Hudson JI. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study. Drug Alcohol Depend. 2003 Jul 20; 71(1):77-86.
    View in: PubMed
    Score: 0.075
  68. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003 Apr 01; 69(3):303-10.
    View in: PubMed
    Score: 0.074
  69. Hudson JI, Mangweth B, Pope HG, De Col C, Hausmann A, Gutweniger S, Laird NM, Biebl W, Tsuang MT. Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003 Feb; 60(2):170-7.
    View in: PubMed
    Score: 0.073
  70. Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG. Pharmacologic treatment of binge eating disorder. Int J Eat Disord. 2003; 34 Suppl:S74-88.
    View in: PubMed
    Score: 0.072
  71. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol. 2002 11; 42(S1):41S-47S.
    View in: PubMed
    Score: 0.071
  72. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001 Oct; 58(10):909-15.
    View in: PubMed
    Score: 0.066
  73. Gruber AJ, Pope HG, Lalonde JK, Hudson JI. Why do young women diet? The roles of body fat, body perception, and body ideal. J Clin Psychiatry. 2001 Aug; 62(8):609-11.
    View in: PubMed
    Score: 0.066
  74. Lalonde JK, Hudson JI, Gigante RA, Pope HG. Canadian and American psychiatrists' attitudes toward dissociative disorders diagnoses. Can J Psychiatry. 2001 Jun; 46(5):407-12.
    View in: PubMed
    Score: 0.065
  75. Kanayama G, Gruber AJ, Pope HG, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001 May-Jun; 70(3):137-40.
    View in: PubMed
    Score: 0.064
  76. Kanayama G, Pope HG, Hudson JI. "Body image" drugs: a growing psychosomatic problem. Psychother Psychosom. 2001 Mar-Apr; 70(2):61-5.
    View in: PubMed
    Score: 0.064
  77. Cannell J, Hudson JI, Pope HG. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law. 2001; 29(2):138-47.
    View in: PubMed
    Score: 0.063
  78. Olivardia R, Pope HG, Hudson JI. Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry. 2000 Aug; 157(8):1291-6.
    View in: PubMed
    Score: 0.061
  79. Pope HG, Oliva PS, Hudson JI, Bodkin JA, Gruber AJ. Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry. 1999 Feb; 156(2):321-3.
    View in: PubMed
    Score: 0.055
  80. Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE, Carter WP, Mitchell JE, Strakowski SM, Pope HG, Coleman BS, Jonas JM. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry. 1998 Dec; 155(12):1756-62.
    View in: PubMed
    Score: 0.054
  81. Pope HG, Hudson JI, Bodkin JA, Oliva P. Questionable validity of 'dissociative amnesia' in trauma victims. Evidence from prospective studies. Br J Psychiatry. 1998 Mar; 172:210-5; discussion 216-7.
    View in: PubMed
    Score: 0.052
  82. Brennan BP, Admon R, Perriello C, LaFlamme EM, Athey AJ, Pizzagalli DA, Hudson JI, Pope HG, Jensen JE. Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram. Psychiatry Res Neuroimaging. 2017 Nov 30; 269:9-16.
    View in: PubMed
    Score: 0.050
  83. Seitz J, Lyall AE, Kanayama G, Makris N, Hudson JI, Kubicki M, Pope HG, Kaufman MJ. White matter abnormalities in long-term anabolic-androgenic steroid users: A pilot study. Psychiatry Res Neuroimaging. 2017 Feb 28; 260:1-5.
    View in: PubMed
    Score: 0.048
  84. Hudson JI, Pope HG, Carter WP, Daniels SR. Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome. J Rheumatol Suppl. 1996 Oct; 46:37-42; discussion 42-3.
    View in: PubMed
    Score: 0.047
  85. Gruber AJ, Hudson JI, Pope HG. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am. 1996 Jun; 19(2):351-69.
    View in: PubMed
    Score: 0.046
  86. Brennan BP, Jensen JE, Perriello C, Pope HG, Jenike MA, Hudson JI, Rauch SL, Kaufman MJ. LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 01; 1(2):116-124.
    View in: PubMed
    Score: 0.045
  87. Hallgren M, Pope HG, Kanayama G, Hudson JI, Lundin A, Källmén H. Anti-Social Behaviors Associated with Anabolic-Androgenic Steroid Use among Male Adolescents. Eur Addict Res. 2015; 21(6):321-6.
    View in: PubMed
    Score: 0.043
  88. Athey AJ, Elias JA, Crosby JM, Jenike MA, Pope HG, Hudson JI, Brennan BP. REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER. J Obsessive Compuls Relat Disord. 2015 Jan 01; 4:20-24.
    View in: PubMed
    Score: 0.042
  89. Phillips KA, McElroy SL, Hudson JI, Pope HG. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry. 1995; 56 Suppl 4:41-51; discussion 52.
    View in: PubMed
    Score: 0.042
  90. Pope HG, Mangweth B, Negrão AB, Hudson JI, Cordás TA. Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian, and Brazilian women. Am J Psychiatry. 1994 May; 151(5):732-7.
    View in: PubMed
    Score: 0.040
  91. Phillips KA, McElroy SL, Keck PE, Hudson JI, Pope HG. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull. 1994; 30(2):179-86.
    View in: PubMed
    Score: 0.039
  92. Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG, Renshaw PF, Cohen BM. A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013 Oct; 33(5):627-35.
    View in: PubMed
    Score: 0.038
  93. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993 Feb; 150(2):302-8.
    View in: PubMed
    Score: 0.036
  94. Hudson JI, Pope HG, Sullivan LE, Waternaux CM, Keck PE, Broughton RJ. Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy. Biol Psychiatry. 1992 Dec 01; 32(11):958-75.
    View in: PubMed
    Score: 0.036
  95. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992 Apr; 92(4):363-7.
    View in: PubMed
    Score: 0.034
  96. Hudson JI, Weiss RD, Pope HG, McElroy SK, Mirin SM. Eating disorders in hospitalized substance abusers. Am J Drug Alcohol Abuse. 1992; 18(1):75-85.
    View in: PubMed
    Score: 0.034
  97. Amiaz R, Pope HG, Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011; 37(4):243-54.
    View in: PubMed
    Score: 0.031
  98. Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG, Renshaw PF, Ongür D. Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology. 2010 Feb; 35(3):834-46.
    View in: PubMed
    Score: 0.029
  99. McElroy SL, Keck PE, Pope HG, Hudson JI. Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol. 1989 Oct; 9(5):358-60.
    View in: PubMed
    Score: 0.029
  100. McElroy SL, Keck PE, Pope HG, Hudson JI. Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry. 1989 Mar; 50 Suppl:23-9.
    View in: PubMed
    Score: 0.028
  101. Pope HG, Hudson JI, Yurgelun-Todd D. Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. J Affect Disord. 1989 Jan-Feb; 16(1):93-9.
    View in: PubMed
    Score: 0.027
  102. Hudson JI, Pope HG, Keck PE, McElroy SL. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol. 1989; 12 Suppl 1:S38-46; Discussion S47-9.
    View in: PubMed
    Score: 0.027
  103. McElroy SL, Keck PE, Pope HG, Hudson JI. Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol. 1988 Aug; 8(4):275-9.
    View in: PubMed
    Score: 0.027
  104. Hudson JI, Pope HG, Wurtman J, Yurgelun-Todd D, Mark S, Rosenthal NE. Bulimia in obese individuals. Relationship to normal-weight bulimia. J Nerv Ment Dis. 1988 Mar; 176(3):144-52.
    View in: PubMed
    Score: 0.026
  105. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D, Frankenburg FR. A controlled family history study of bulimia. Psychol Med. 1987 Nov; 17(4):883-90.
    View in: PubMed
    Score: 0.025
  106. Hudson JI, Pope HG, Yurgelun-Todd D, Jonas JM, Frankenburg FR. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry. 1987 Oct; 144(10):1283-7.
    View in: PubMed
    Score: 0.025
  107. Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004 Aug 16; 75(2):135-47.
    View in: PubMed
    Score: 0.020
  108. Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003 Nov; 33(8):1415-22.
    View in: PubMed
    Score: 0.019
  109. McElroy SL, Pope HG, Hudson JI, Keck PE, White KL. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991 May; 148(5):652-7.
    View in: PubMed
    Score: 0.008
  110. McElroy SL, Hudson JI, Pope HG, Keck PE. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med. 1991 Feb; 21(1):93-108.
    View in: PubMed
    Score: 0.008
  111. McElroy SL, Keck PE, Pope HG, Hudson JI, Morris D. Correlates of antimanic response to valproate. Psychopharmacol Bull. 1991; 27(2):127-33.
    View in: PubMed
    Score: 0.008
  112. Keck PE, Pope HG, Hudson JI, McElroy SL, Yurgelun-Todd D, Hundert EM. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry. 1990 Jul-Aug; 31(4):275-83.
    View in: PubMed
    Score: 0.008
  113. Zanarini MC, Frankenburg FR, Pope HG, Hudson JI, Yurgelun-Todd D, Cicchetti CJ. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry. 1990 Jan-Feb; 31(1):20-4.
    View in: PubMed
    Score: 0.007
  114. Aranow AB, Hudson JI, Pope HG, Grady TA, Laage TA, Bell IR, Cole JO. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry. 1989 Jul; 146(7):911-3.
    View in: PubMed
    Score: 0.007
  115. Keck PE, Pope HG, Hudson JI, McElroy SL, Kulick AR. Lycanthropy: alive and well in the twentieth century. Psychol Med. 1988 Feb; 18(1):113-20.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.